- $82.75bn
- $97.35bn
- $8.19bn
- 94
- 11
- 93
- 72
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5,562 | 5,999 | 6,636 | 7,263 | 8,188 |
Cost of Revenue | |||||
Gross Profit | 2,752 | 2,924 | 3,163 | 3,512 | 3,960 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4,445 | 5,091 | 5,643 | 6,062 | 6,745 |
Operating Profit | 1,117 | 907 | 993 | 1,201 | 1,443 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 693 | 516 | 609 | 829 | 1,124 |
Provision for Income Taxes | |||||
Net Income After Taxes | 507 | 370 | 500 | 705 | 969 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 507 | 370 | 500 | 704 | 969 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 507 | 370 | 500 | 704 | 969 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 6.42 | 5.87 | 6.97 | 7.99 | 10.4 |
Dividends per Share |